Pharmaceuticals India News
  • Home
  • Brands
    • Alkem
    • Apollo Hospital
    • Aurobindo Pharma
    • Biocon
    • Cipla
    • Divi’s Laboratories
    • Dr Reddy’s
    • Fortis
    • Glenmark
    • Lupin
    • Mankind Pharma
    • Natco
    • Pfizer
    • Piramal Pharma
    • Sun Pharma
    • Torrent Pharma
    • Zydus
Select Page

Glenmark Pharma’s Chairman and Managing Director emphasized the importance of maintaining concentration and undertaking initiatives that are on par with global standards.

by Team Small News | Jun 18, 2025 | Glenmark, Pharma

Glenn Saldanha, Chairman and Managing Director of Glenmark Pharmaceuticals Ltd, reflects on the company’s over two-decade journey, highlighting the challenges of transitioning from a generic-focused business to a more innovative space. Saldanha notes that this...

Meet India’s oldest billionaire, owner of Alkem Labs, who proudly owns a luxurious multi-crore Rolls Royce Cullinan.

by Team Small News | Jun 18, 2025 | Alkem, Pharma

India’s oldest billionaire, Samprada Singh, has become the proud owner of a brand-new Rolls-Royce Cullinan. At 93 years old, Singh is not only the oldest man in India to own this luxury vehicle, but he is also the billionaire owner of Alkem Labs, a leading...

Get to know the sibling duo born on the same day, who are the masterminds behind one of India’s largest pharmaceutical companies, valued at a staggering Rs 97,572 crore.

by Team Small News | Jun 17, 2025 | Mankind, Pharma

Mankind Pharma, a leading pharmaceutical company in India, was founded by brothers Ramesh and Rajeev Juneja in 1995 with a modest capital of Rs 50 lakh and just 20 employees. Today, the company is the fourth-largest pharmaceutical company in India, with a market...
Alvotech and Dr. Reddy’s collaborate to create a biosimilar version of the cancer treatment Pembrolizumab.

Alvotech and Dr. Reddy’s collaborate to create a biosimilar version of the cancer treatment Pembrolizumab.

by Team Small News | Jun 17, 2025 | Dr Reddy's

Alvotech, a global biopharmaceutical company, has partnered with Dr. Reddy’s Laboratories, a leading pharmaceutical company, to develop a biosimilar for the cancer drug pembrolizumab. Pembrolizumab, marketed under the brand name Keytruda, is a monoclonal...

Pfizer acquires international rights, excluding China, for 3SBio’s innovative cancer treatment SSGJ-707, a dual-target therapy.

by Team Small News | Jun 17, 2025 | Pfizer, Pharma

Pfizer has recently secured the global rights outside of China for 3SBio’s dual-target cancer therapy, SSGJ-707. This deal marks a significant collaboration between the two companies, with Pfizer gaining exclusive rights to develop, manufacture, and...
« Older Entries
Next Entries »

_________

Pharna Brands

  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma
  • Torrent Pharma
  • Zydus
  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Torrent Pharma
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Zydus
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma

    Designed by Elegant Themes | Powered by WordPress